Abstract
The amyloid precursor protein (APP) is a glycoprotein consisting of at least four isoforms derived from a single gene by a process of alternative splicing. The membrane-bound forms of APP have been suggested to have adhesive properties and to mediate neural cell adhesion. Previous studies have demonstrated the ability of Fab’ fragments of antibodies to extracellular domains of APP to inhibit neural cell binding to a collagen substrate, suggesting a physiological role for the collagen-binding properties of APP.
The binding of APP has been demonstrated to be specific for type IV collagen, and no binding to other extracellular matrix components, including fibronectin and laminin, was detected. The APP-collagen binding appeared to be mediated by a heparin-bridge mechanism, since the binding was abolished by the addition of excess heparan or heparinase. These results were observed by both a homogenatecollagen binding assay and a cell-surface adhesion assay, thus providing further evidence for the adhesion role of APP. They also pose the question of the possible role of the heparin-binding properties of APP in the genesis of the neuritic plaques characteristic of Alzheimer’s disease.
Similar content being viewed by others
References
Breen K. C., Bruce M., and Anderton B. H. (1991) Beta amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion.J. Neurosci. Res. 28, 90–100.
Chen M. and Yankner B. A. (1991) An antibody to β-amyloid and the amyloid precursor protein inhibits cell substratum adhesion in many mammalian cell types.Neurosci. Lett. 125, 223–226.
Cole G. and Glaser L. (1986) A heparin-binding domain from N-CAM is involved in neural cell-substratum adhesion.J. Cell Biol. 102, 403–412.
Cole G. J., Lowey A., and Glaser L. (1986) Neuronal cell-cell adhesion depends on interactions of N-CAM with heparin-like molecules.Nature 320, 445–447.
de Sauvage F. and Octave J. N. (1989) A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein.Science 245, 651–654.
Doyle E., Bruce M., Breen K. C., Smith D. C., Anderton B., and Regan C. M. (1990) Intraventricular infusion of antisera to the Alzheimer amyloid precursor protein impairs the acquisition of a passive avoidance paradigm in the rat.Neurosci. Lett 115, 97–012.
Dyrks T., Weidemann A., Malthaup G., Salbaum J. M., Lemaire U. G., Kang J., Muller-Hill B., Masters C. L., and Beyreuther K. (1988) Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer’s disease.EMBO J. 7, 949–957.
Guiroy D. C., Bogucki A., Papierz W., Liberski P. P., and Yanagihara R. (1991) Amyloid b-protein in cerebral angiopathy, senil plaques and preamyloidotic lesions in subcortical arteriosclerotic encephalopathy (Binswanger disease).Neurosci. Lett. 124, 31–34.
Howard J. and Pilkington G. J. (1990) Antibodies to fibronectin bind to plaques and other structures in Alzheimer’s disease and control brain.Neurosci. Lett. 118, 71–76.
Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschic K. H., Multhaup G., Beyreuther K., and Muller-Hill B. (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell surface receptor.Nature 325, 733–736.
Katzman R. and Saitoh T. (1991) Advances in Alzheimer’s disease.FASEB J. 5, 278–286.
Kawai M., Kalaria R. N., Harik S. I. and Perry G. (1990) The relationship of amyloid plaques to cerebral capillaries in Alzheimer’s disease.Am. J. Pathol. 137, 1435–1446.
Kisilevsky R., Narindrasorasak S., Lowery D., Gonzalev-DeWhitt P., Poorman R. A., & Greenberg B. (1991) High affinity binding of heparan sulfate proteoglycan to the Alzheimer beta amyloid precursor proteins.FASEB J. 5, A7168.
Kitaguchi N., Takahashi Y., Shiajiri S., and Ito H. (1988) Novel precursors of Alzheimer’s disease amyloid protein shows protease inhibitory activity.Nature 331, 530–532.
Klier F. G., Cole G., Stallcup W., and Schubert D. (1990) Amyloid β-protein is associated with extracellular matrix.Brain Res. 515, 336–342.
Koh J. Y., Yang L. L., and Cotman C. W. (1990) b-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage.Brain Res. 533, 315–320.
Kowall N. W. and McKee A. C. (1990) Laminin immunoreactivity is increased in Alzheimer Disease hippocampus.Soc. Neurosci. Abstr. 16, 461.
Lander A. D. (1989) Understanding the molecules of neural cell contacts: Emerging patterns of structure and function.Trends in Neurosci. 12, 189–195.
Lowry G. H., Rosenbrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the folin reagent.J. Biol. Chem. 193, 265–275.
Martin M. L. and Regan C. M. (1988) The anti-convulsant sodium valproate specifically induces the expression of a rat glial heat shock protein which is identified as the collagen type IV receptor.Brain Res. 459, 131–137.
Octave J. N., de Sauvage F., and Maloteaux J. M. (1989) Modification of neuronal cell adhesion affects the genetic expression of the A4 amyloid peptide precursor.Brain Res. 486, 369–371.
Ohyagi Y., Takahashi K., Kamegai M., and Tabira T. (1990) Developmental and differential expression of beta amyloid protein precursor mRNAs in mouse brain.Biochem. Biophys. Res. Comm. 167, 54–60.
Oltersdorf T., Fritz L. C., Schenk D. B., Lieberburg I., Johnson-Wood K. L., Beattie E. C., Ward P. J., Blacher R. W., Dovey H. F., and Sinka S. (1989) The secreted form of the Alzheimer’s amyloid precursor protein with the Kunitz domain is protease nexin II.Nature 341, 144–147.
Perlmutter L. S., Chui H. C., Saperia D., and Athanikar J. (1990) Microangiopathy and the colocalisation of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer’s disease.Brain Res. 508, 13–19.
Ponte P., Gonzalez de Whitt P., Schilling J., Miller J., Hsu D., Greenberg B., Davis K., Wallace W., Liberburg I., Fuller F., and Cardell B. (1988) A new amyloid mRNA contains a domain homologous to serine protease inhibitors.Nature 331, 525–527.
Saitoh T., Sundsmo H., Roch J. M., Kimura N., Cole G., Schubert D., Oltersdorf T., and Schenk D. B. (1989) Secreted forms of amyloid protein precursor is involved in the growth regulation of fibroblasts.Cell 58, 615–622.
Shubert D., Schroeder R., LaCorbiere M., Saitoh T., and Cole G. (1988) Amyloid β-protein precursor is possibly a heparin sulfate proteoglycan cotre protein.Science 241, 223–226.
Schubert D., LaCorbiere M., Saitoh T., and Cole G. (1989a) Characterisation of an amyloid precursor protein that binds heparin and contains tyrosine sulfate.Proc. Nat. Acad. Sci. (USA) 85, 2066–2069.
Schubert D., Lin L. W., Saitoh T., and Cole G. (1989b) The regulation of amyloid b protein precursor secretion and its modulatory role in cell adhesion.Neuron 3, 689–694.
Selkoe D. J., Podlinsky M. B., Joachim C. L., Vickers E. A., Lee G., Fritz L. C., and Oltersdorf T. (1988) β-amyloid precursor protein of Alzheimer disease occurs as 110 to 135-kilodalton membrane-associated proteins in neural and non-neural tissues.Proc. Nat. Acad. Sci. USA 85, 7341–7345.
Shivers B. D., Hilbich C., Multhaup G., Salbaum M., Beyreuther K., and Seeburg P. H. (1988) Alzheimer’s disease amyloidogenic glycoprotein-expression pattern in the rat brain suggests a role in cell contact.EMBO J. 7, 1365–1370.
Sisodia S. S., Koo E. H., Beyreuther K., Unterbeck A., and Price D. L. (1990) Evidence that beta-amyloid in Alzheimer’s disease is not derived by normal processing.Science 248, 492–495.
Smith R. P. Higuchi D. A., and Broze G. J. (1990) Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein.Science 248, 1126–1128.
Snow A. D., Willmer J., and Kisilevsky R. (1987a) Sulfated glycosaminoglycans: A common constituent of all amyloids?Lab. Invest. 56, 120–123.
Snow A. D., Willmer J., and Kisilevsky R. (1987b) Sulfated glycosaminoglycans in Alzheimer’s disease.Hum. Pathol. 18, 506–510.
Snow A. D., Wight T. N., Nochlin D., Koike Y., Kimata K., Dearmond S. J., and Pruisner S. B. (1990) Immunolocalisation of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome. Creuzfeldt-Jakob disease and scrapie.Lab. Invest. 63, 601–611.
Strong M. J., Svedmyr A., Gajdusek D. C., and Garruto R. M. (1990) The temporal expression of amyloid precursor protein mRNA in vitro in dissociated hippocampal neuron cultures.Exp. Neurol. 109, 171–179.
Tanzi R. E., McClatchey A. I., Lamperti E. D., Villa-Komoroff L., Gusella J. F., and Neve R. L. (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer’s disease.Nature 331, 528–530.
Van Nostrand W. E., Wagner S. L., Suzuki M., Choi B. H., Farrow J. S. Cotman C. W., and Cunningham D. D. (1989) Protease nexin II, a potent antichumotrypsin, shows identity to amyloid β-precursor protein.Nature 341, 546–549.
Weidemann A., Konig G., Bunke D., Fischer P., Salbaum J. M., Masters C. L., and Beyreuther K. (1989) Identification, biogenesis and localisation of precursors of Alzheimer’s disease A4 amyloid protein.Cell 57, 115–126.
Whitson J. S., Selkoe D. J., and Cotman C. W. (1989) Amyloid β-protein enhances the survival of hippocampal neurons in vitro.Science 243, 1488–1490.
Yankner B. A., Dawes L. R., Fisher S., Villa-Komaroff L. Oster-Granite M. L., and Neve R. L. (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease.Science 245, 417–420.
Yankner B. A., Duffy L. K., and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinan neuropeptides.Science 250, 279–282.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Breen, K.C. APP-collagen interaction is mediated by a heparin bridge mechanism. Molecular and Chemical Neuropathology 16, 109–121 (1992). https://doi.org/10.1007/BF03159964
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03159964